Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Can Anti-Parasitic Drugs Help Control Covid-19? Publisher



Panahi Y1 ; Dadkhah M2 ; Talei S3 ; Gharari Z4 ; Asghariazar V5 ; Abdolmaleki A6, 7 ; Matin S8 ; Molaei S2, 9
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pharmacology and Toxicology, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran
  2. 2. Pharmaceutical Sciences Research Center, Ardabil University of Medical Sciences, Ardabil, Iran
  3. 3. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Biotechnology, Faculty of Biological Sciences, Al-Zahra University, Tehran, Iran
  5. 5. Deputy of Research and Technology, Ardabil University of Medical Sciences, Ardabil, Iran
  6. 6. Department of Engineering Sciences, Faculty of Advanced Technologies, University of Mohaghegh Ardabili, Namin, Iran
  7. 7. Bio Science and Biotechnology Research center (BBRC), Sabalan University of Advanced Technologies (SUAT), Namin, Iran
  8. 8. Department of Internal Medicine, Imam Khomeini Hospital, Ardabil University of Medical Sciences, Ardabil, Iran
  9. 9. Zoonoses Research Center, Ardabil University of Medical Sciences, Ardabil, Iran

Source: Future Virology Published:2022


Abstract

Novel COVID-19 is a public health emergency that poses a serious threat to people worldwide. Given the virus spreading so quickly, novel antiviral medications are desperately needed. Repurposing existing drugs is the first strategy. Anti-parasitic drugs were among the first to be considered as a potential treatment option for this disease. Even though many papers have discussed the efficacy of various anti-parasitic drugs in treating COVID-19 separately, so far, no single study comprehensively discussed these drugs. This study reviews some anti-parasitic recommended drugs to treat COVID-19, in terms of function and in vitro as well as clinical results. Finally, we briefly review the advanced techniques, such as artificial intelligence, that have been used to find effective drugs for the treatment of COVID-19. © 2022 Future Medicine Ltd.
Related Docs
View other Related Docs
1. An Overview on the Treatments and Prevention Against Covid-19, Virology Journal (2023)
2. Covid-19: Transmission, Prevention, and Potential Therapeutic Opportunities, Clinica Chimica Acta (2020)
3. Classification of the Present Pharmaceutical Agents Based on the Possible Effective Mechanism on the Covid-19 Infection, DARU# Journal of Pharmaceutical Sciences (2020)
4. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
5. Safety and Efficacy of Hydroxychloroquine and Chloroquine in Treatment of Covid-19: A Rapid Review of Evidence, Health Technology Assessment in Action (2020)
6. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
7. Post-Exposure Prophylaxis for Covid-19: A Systematic Review, Infectious Disorders - Drug Targets (2023)
8. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (22)
Seyed Ahmad Seyed Alinaghi (7)
Other Related Docs
9. Covid-19: A Review on Treatment Strategies and Candidate Vaccines, Scientific Journal of Kurdistan University of Medical Sciences (2021)
10. Immunopathological Similarities Between Covid-19 and Influenza: Investigating the Consequences of Co-Infection, Microbial Pathogenesis (2021)
11. Variants in Ace2; Potential Influences on Virus Infection and Covid-19 Severity, Infection# Genetics and Evolution (2021)
12. Novel Therapeutic Approaches for Treatment of Covid-19, Journal of Molecular Medicine (2020)
13. Current Treatments and Therapeutic Options for Covid-19 Patients: A Systematic Review, Infectious Disorders - Drug Targets (2022)
14. Covid-19: A Systematic Review and Update on Prevention, Diagnosis, and Treatment, MedComm (2022)
15. Remdesivir: A Beacon of Hope From Ebola Virus Disease to Covid-19, Reviews in Medical Virology (2020)
16. Effect the Pre-Exposure Prophylactic of Hydroxychloroquine on Severe Covid-19 Disease: A Randomized Controlled Trial; [Влияние Доконтактной Профилактики Гидроксихлорохином На Развитие Тяжелого Covid-19: Рандомизированное Контролируемое Исследование], Russian Journal of Infection and Immunity (2023)
17. Sars-Cov-2: A Comprehensive Review From Pathogenicity of the Virus to Clinical Consequences, Journal of Medical Virology (2020)
18. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
19. The Situation of Small Molecules Targeting Key Proteins in Combatting Sars-Cov-2: Synthesis, Metabolic Pathway, Mechanism of Action, and Potential Therapeutic Applications, Mini-Reviews in Medicinal Chemistry (2022)
20. Recent Findings on the Coronavirus Disease 2019 (Covid-19); Immunopathogenesis and Immunotherapeutics, International Immunopharmacology (2020)
21. Computational Drug Discovery and Repurposing for the Treatment of Covid-19: A Systematic Review, Bioorganic Chemistry (2021)
22. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
23. Targeted Therapy Strategies Against Sars-Cov-2 Cell Entry Mechanisms: A Systematic Review of in Vitro and in Vivo Studies, Journal of Cellular Physiology (2021)
24. Covid-19: Review of a 21St Century Pandemic From Etiology to Neuro-Psychiatric Implications, Journal of Alzheimer's Disease (2020)
25. The Prophylaxis and Treatment Potential of Supplements for Covid-19, European Journal of Pharmacology (2020)
26. Severe Acute Respiratory Syndrome-Coronavirus-2 Spike (S) Protein Based Vaccine Candidates: State of the Art and Future Prospects, Reviews in Medical Virology (2021)
27. Immunomodulatory-Based Therapy As a Potential Promising Treatment Strategy Against Severe Covid-19 Patients: A Systematic Review, International Immunopharmacology (2020)
28. The Chimera of S1 and N Proteins of Sars-Cov-2: Can It Be a Potential Vaccine Candidate for Covid-19?, Expert Review of Vaccines (2022)
29. Cardiovascular Considerations in Treating Patients With Coronavirus Disease 2019 (Covid-19), Journal of Cardiovascular Pharmacology (2020)
30. Characteristics of Published/Registered Clinical Trials on Covid-19 Treatment: A Systematic Review, DARU# Journal of Pharmaceutical Sciences (2021)
31. The Role of Autophagy in Controlling Sars-Cov-2 Infection: An Overview on Virophagy-Mediated Molecular Drug Targets, Cell Biology International (2021)
32. Clinical Outcomes of Patients With Mild Covid-19 Following Treatment With Hydroxychloroquine in an Outpatient Setting, International Immunopharmacology (2021)
33. Effect of Covid-19 Medications on Corrected Qt Interval and Induction of Torsade De Pointes: Results of a Multicenter National Survey, International Journal of Clinical Practice (2021)
34. Safety and Effectiveness of Azithromycin in Patients With Covid-19: An Open-Label Randomised Trial, International Journal of Antimicrobial Agents (2020)
35. Vitamin D Supplementation and Calcium: Many-Faced Gods or Nobody in Fighting Against Corona Virus Disease 2019, Clinical Nutrition ESPEN (2024)
36. Molecular Aspects of Co-Morbidities in Covid-19 Infection, Archives of Bone and Joint Surgery (2020)
37. A Theoretical Strategy for Acceleration of Human Immune Response Against Sars-Cov-2: A Fusion Protein Harboring Virus-Binding and Pre-Exposed Antigen Domains, VirusDisease (2021)
38. Coronavirus Disease 2019 (Covid-19) in Pediatric Patients With Autoimmune Disorders, European Journal of Pediatrics (2023)
39. Febuxostat Therapy in Outpatients With Suspected Covid-19: A Clinical Trial, International Journal of Clinical Practice (2020)
40. State-Of-The-Art of Nanodiagnostics and Nanotherapeutics Against Sars-Cov-2, ACS Applied Materials and Interfaces (2021)
41. Recent Advances in Antibody-Based Immunotherapy Strategies for Covid-19, Journal of Cellular Biochemistry (2021)
42. Prophylaxis With Chloroquine and Hydroxychloroquine in Covid-19, Journal of Iranian Medical Council (2020)
43. Clinical Symptoms and Types of Samples Are Critical Factors for the Molecular Diagnosis of Symptomatic Covid-19 Patients: A Systematic Literature Review, International Journal of Microbiology (2021)
44. Prevention of Covid-19: Preventive Strategies for General Population, Healthcare Setting, and Various Professions, Advances in Experimental Medicine and Biology (2021)
45. Real Clinical Practice and Therapeutic Management Following Covid-19 Crisis in Two Hospitals in Iran: A Statistical and Conceptual View, Tanaffos (2020)
46. Repurposing Antiparasitic Drugs for the Treatment of Other Diseases, Advances in Antiparasitic Therapies and Drug Delivery (2023)
47. A Narrative Literature Review on Traditional Medicine Options for Treatment of Corona Virus Disease 2019 (Covid-19), Complementary Therapies in Clinical Practice (2020)
48. Existing Antiviral Options Against Sars-Cov-2 Replication in Covid-19 Patients, Future Microbiology (2020)
49. Baricitinib: From Rheumatoid Arthritis to Covid-19, Journal of Clinical Pharmacology (2021)
50. Therapeutic Potentials and Candidates for Covid-19, Iranian Journal of Science (2023)